Maxim Rossmann, Ph.D. Biochemistry

CEO, co-founder

Over 15 years experience in molecular biology, cancer biology, biochemical and biophysical techniques for development of molecular therapies.

Irina Soltamova Solovyev, M.Sc. Economics

CFO, co-founder

Over 25 years experience in financial and business consulting and auditing.Strong expertise in Due Diligence, International Financial Reporting Standards, Financial Modelling, International Taxation for the large producing, insurance and financial corporations.

Dmitry Soloviev, Ph.D. Chemistry, MRSC

Clinical lead, co-founder

Over 25 years experience in development of diagnostic radiopharmaceuticals for Positron Emission Tomography. Expert in GMP production of cyclotron-produced radiopharmaceuticals at IAEA, Vienna.

Rebecca Stacey, B.Sc. Biochemistry

Laboratory scientist

Rebecca graduated from Liverpool John Moores University with a 2:2 Bsc in Biochemistry. She has a vast amount of experience within the food industry, microbiology and ELISA machinery. Rebecca has full training in X-Ray fluorescence spectroscopy, sample preparation and XRF data analysis.

Simon Roff, HNC Engineering

Quality Management

Over 30 years experience in innovative medical device design and manufacture, new product support, introduction,

validation and testing, risk management of products, research and development of new technology for IP, Health and Safety,

COSHH implementation, quality management and GMP.

Prof. Mark Emberton

Dean of UCL Faculty of Medical Sciences and Professor of Interventional Oncology at UCL

Mark Emberton’s principal interests lie in trying to improve diagnostic and therapeutic pathways for men with prostate cancer, principally through the use of novel diagnostic, imaging techniques and minimally-invasive treatments

Prof. Lutz Schomburg Ph.D. Biochemistry

Scientific Adviser, co-founder

Prof. for Experimental Endocrinology, Vice Director Institute for Experimental Endocrinology, Charité – Universitätsmedizin Berlin. Over 20 years experience in endocrinology, development and validation of novel In Vitro Diagnostic Assays.

Sir Michael Snyder

DSc, FRSA, FCA, FInstD, MSI Honorary Head of Advisory Board

Consultant and former Senior Partner of top-20 Chartered Accountants Kingston Smith LLP. Among numerous assignments he was Chairman of the Association of Practicing Accountants, served as Co-Chairman of the Government’s Professional Business Services Council and lead the City Corporation as Policy and Resources Chairman. He is currently a Non-Executive Director of Metro Bank.

Prof. Vladimir Zaichick, Ph.D. Physics, FRSC

Scientific Adviser

Over 50 years experience in medicinal physics and diagnostic method development. Prof. Zaichick’s long and fruitful scientific career was dedicated to studying elemental and chemical composition of human organs. He pioneered development of numerous novel in vivo and in vitro cancer diagnostic tests.